WALDENSTRÖM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood cancer: targeted drug zanubrutinib tested in chinese patients
Disease control Recruiting nowThis study tests the drug zanubrutinib in 18 Chinese adults with Waldenström macroglobulinemia who have not yet received treatment. The goal is to see how well the drug controls the cancer and to check for side effects. Participants take the drug by mouth, and the study will meas…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: BeiGene • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Real-world study tracks blood cancer drug's impact on daily life
Knowledge-focused Recruiting nowThis study is observing adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are taking the drug zanubrutinib. Researchers want to see how often patients need hospital care and how their quality of life chan…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC